Business ❯ Corporate Governance ❯ Shareholder Rights ❯ Litigation

Securities Fraud

Rosen Law Seeks Lead Plaintiff in ImmunityBio Securities Suit After FDA Ad Warning

The case centers on an FDA warning that ImmunityBio’s promotions for Anktiva overstated the drug’s benefits.

Medpace Investors Invited to Seek Lead Role in Securities Suit by June 8

Oddity Tech Hit With Securities Suits After Ad-Algorithm Disruption and 49% Stock Plunge

Varonis Investors Face March 9 Deadline to Lead Securities Class Action Over SaaS Conversion Claims

SLM Securities Class Action Enters Lead-Plaintiff Phase Ahead of Feb. 17 Deadline

Jayud Securities Suits Push Investors Toward Jan. 20 Lead-Plaintiff Deadline

Blue Owl Investors Face Feb. 2 Deadline in Securities Class Action Over BDC Redemption Disclosures

CarMax Securities Litigation Intensifies With Expanded Class Period and Jan. 2 Lead-Plaintiff Deadline

Fluor Hit With Securities Class Action Over Cost Overruns and 2025 Guidance